\
&
Contact us
\
&
Contact us
This was 8 months ago
LocationOnline
ProgrammesThe ERA4Health Partnership organises a webinar on Responsible Research and Innovation (RRI) and the integration of cutting-edge technologies such as Artificial Intelligence into healthcare systems.
During the webinar, Dr. Michal Rosen-Zvi, Director of Health and Life Sciences at IBM Research, Chief Scientist of the Cleveland Clinic–IBM Discovery Accelerator, and Associate Professor of Computational Medicine at the Hebrew University of Jerusalem, will present the transformative potential of generative AI technologies in healthcare, from accelerating drug discovery to supporting clinical decision-making. She will also address the ethical and regulatory challenges posed by data bias and privacy, emphasizing the importance of developing fair, transparent, and accountable AI systems tailored for medical applications.
Please use this link to register for the event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
